Skip to main
HUM

Humana (HUM) Stock Forecast & Price Target

Humana (HUM) Analyst Ratings

Based on 17 analyst ratings
Hold
Strong Buy 18%
Buy 24%
Hold 53%
Sell 0%
Strong Sell 6%

Bulls say

Humana is well-positioned in the healthcare industry due to its strong focus on government-sponsored programs, which make up a majority of its membership. With the expected 25% y/y growth in Individual MA membership and recontracting in the Group MA sector, Humana is poised for continual growth. The company has also been actively managing its medical and Rx trends, leading to better financial performance, and we expect this trend to continue in the foreseeable future.

Bears say

Humana is a healthcare company that specializes in government-sponsored programs such as Medicare, Medicaid, and Tricare. However, with a recent downturn in the Medicare Advantage program and uncertainty surrounding future margins, we believe Humana may struggle to maintain its current level of profitability. Additionally, the company's reliance on government programs exposes it to potential changes in regulations and reimbursements.

Humana (HUM) has been analyzed by 17 analysts, with a consensus rating of Hold. 18% of analysts recommend a Strong Buy, 24% recommend Buy, 53% suggest Holding, 0% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Humana and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Humana (HUM) Forecast

Analysts have given Humana (HUM) a Hold based on their latest research and market trends.

According to 17 analysts, Humana (HUM) has a Hold consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $382, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $382, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Humana (HUM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.